SEC Form 4Coverage since Jun 12, 2026
$PBYI insider trading
Over the last 12 months, Puma Biotechnology insiders reported no purchases and 8 sales totaling $1.1M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $1.1M 8 events
- Events · 12m
- 8 Form 4 filings, grouped
- Insiders · 12m
- 8 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $PBYI · 12Mvia TradingView
Top insiders · 12m
Stuglik Brian M—1× · $58K
HUNT DOUGLAS MSee Remarks1× · $70K
NOUGUES MAXIMO FChief Financial Officer1× · $78K
WILSON TROY EDWARD—1× · $78K
Dorval Allison—1× · $84K
All insider trades
8 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | AUERBACH ALAN HPresident and CEO · O·D·10% | ▼ Sale | 44,058 | $8.26 | $364K | -0.6% | plan |
| Jul 6, 2026 | HUNT DOUGLAS MSee Remarks · O | ▼ Sale | 8,460 | $8.26 | $70K | -4.1% | plan |
| Jul 6, 2026 | NOUGUES MAXIMO FChief Financial Officer · O | ▼ Sale | 9,386 | $8.26 | $78K | -3.9% | plan |
| Jun 12, 2026 | WILSON TROY EDWARDD | ▼ Sale | 10,800 | $7.2 | $78K | -15.3% | plan |
| Jun 12, 2026 | Stuglik Brian MD | ▼ Sale | 8,100 | $7.2 | $58K | -6.6% | plan |
| Jun 12, 2026 | Senderowicz AdrianD | ▼ Sale | 27,000 | $7.2 | $194K | -50% | plan |
| Jun 12, 2026 | MOYES JAY MD | ▼ Sale | 22,000 | $7.22 | $159K | -27.4% | plan |
| Jun 12, 2026 | Dorval AllisonD | ▼ Sale | 11,610 | $7.2 | $84K | -11.3% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $PBYI feed.